In this study, we have investigated whether oxLDL, largely involved in atherosclerosis progression, impacts the expression of two oxLDL receptors, CD36 and Lox-1, in head and neck cancer (HNC) cell lines. The gene discussed is CD36; the disease is head and neck cancer.